“Pharmacotherapeutic and laboratory profile analysis of patients with secondary hyperparathyroidism submitted to parathyroidectomy”, RSD, vol. 11, no. 5, p. e16511527949, Apr. 2022, doi: 10.33448/rsd-v11i5.27949.